Terms: = Liver cancer AND BCL7A, BCL7, 605, ENSG00000110987 AND Treatment
34 results:
1. Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
Cao B; Wang Y; Lu H; Huang C; Yang Y; Shang L; Chen Z; Jiang R; Liu Y; Lin L; Peng P; Wang F; Gong F; Hu H; Cheng C; Yao X; Ye X; Zhou H; Shen Y; Liu C; Wang C; Yi Z; Hu B; Xu J; Gu X; Shen J; Xu Y; Zhang L; Fan J; Tang R; Wang C
N Engl J Med; 2024 Jan; 390(3):230-241. PubMed ID: 38231624
[TBL] [Abstract] [Full Text] [Related]
2. Factors associated with all-cause mortality in tuberculosis patients in a Malaysian tertiary hospital.
Wong CK; Ng KS; Choo SQR; Lee CJ; Teo YP; Liew SM; Chinna K; Khoo EM; Ng WL; Tok PSK; Kee YS; Chiang M
J Infect Dev Ctries; 2023 Aug; 17(8):1138-1145. PubMed ID: 37699097
[TBL] [Abstract] [Full Text] [Related]
3. Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab treatment for Unresectable Hepatocellular Carcinoma.
Tajiri K; Tsukada K; Tokimitsu Y; Motofuji Y; Kawai K; Muraishi N; Murayama A; Hayashi Y; Shimizu Y; Yasuda I
Oncology; 2024; 102(2):131-140. PubMed ID: 37666216
[TBL] [Abstract] [Full Text] [Related]
4. Serum cell division cycle 42 in advanced hepatocellular carcinoma patients: Linkage with clinical characteristics and immune checkpoint inhibitor-related treatment outcomes.
Xu J; Shao R; Zhang X; Yao D; Han S
Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102149. PubMed ID: 37247692
[TBL] [Abstract] [Full Text] [Related]
5. Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of cancers During Chemoradiation Therapy: Real-World Study.
Kang D; Kim S; Kim H; Lee M; Kong SY; Chang YJ; Sim SH; Kim YJ; Cho J
JMIR Public Health Surveill; 2023 Mar; 9():e44105. PubMed ID: 36884274
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy and safety of single- and multiple-antenna microwave ablation for the treatment of hepatocellular carcinoma and liver metastases: A systematic review and network meta-analysis.
Han Y; Zhao W; Wu M; Qian Y
Medicine (Baltimore); 2022 Dec; 101(51):e32304. PubMed ID: 36595779
[TBL] [Abstract] [Full Text] [Related]
7. Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based on digital subtraction angiography videos.
Zhang L; Jiang Y; Jin Z; Jiang W; Zhang B; Wang C; Wu L; Chen L; Chen Q; Liu S; You J; Mo X; Liu J; Xiong Z; Huang T; Yang L; Wan X; Wen G; Han XG; Fan W; Zhang S
Cancer Imaging; 2022 May; 22(1):23. PubMed ID: 35549776
[TBL] [Abstract] [Full Text] [Related]
8. Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma.
Rhee H; Choi SH; Park JH; Cho ES; Yeom SK; Park S; Han K; Lee SS; Park MS
Liver Int; 2022 Apr; 42(4):930-941. PubMed ID: 35152534
[TBL] [Abstract] [Full Text] [Related]
9. Early detection of treatment futility in patients with metastatic colorectal cancer.
Rattner JI; Kopciuk KA; Vogel HJ; Tang PA; Shapiro JD; Tu D; Jonker DJ; Siu LL; O'Callaghan CJ; Bathe OF
Oncotarget; 2022; 13():61-72. PubMed ID: 35028011
[TBL] [Abstract] [Full Text] [Related]
10. [Effect of HBV infection pattern on prevalence of fatty liver disease in Jinchang cohort].
Zhang WL; Bai YN; Zhang DS; Zhao YY; Yin C; Huo YB; Ding J; Ba YP; Li N; Gan T; Wang YF; Cheng N
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Mar; 42(3):488-492. PubMed ID: 34814418
[No Abstract] [Full Text] [Related]
11. Anatomical sites (Takasaki's segmentation) predicts the recurrence-free survival of hepatocellular carcinoma.
Qin W; Wang L; Hu B; Tian H; Xiao C; Luo H; Yang Y
BMC Surg; 2021 Jun; 21(1):278. PubMed ID: 34082743
[TBL] [Abstract] [Full Text] [Related]
12. The m6A methylation landscape stratifies hepatocellular carcinoma into 3 subtypes with distinct metabolic characteristics.
Shen X; Hu B; Xu J; Qin W; Fu Y; Wang S; Dong Q; Qin L
Cancer Biol Med; 2020 Nov; 17(4):937-952. PubMed ID: 33299645
[TBL] [Abstract] [Full Text] [Related]
13. A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function.
Nam JY; Choe AR; Sinn DH; Lee JH; Kim HY; Yu SJ; Kim YJ; Yoon JH; Lee JM; Chung JW; Choi SY; Lee JK; Baek SY; Lee HA; Kim TH; Yoo K
BMC Cancer; 2020 Jun; 20(1):504. PubMed ID: 32487089
[TBL] [Abstract] [Full Text] [Related]
14. SNHG16/miR-605-3p/TRAF6/NF-κB feedback loop regulates hepatocellular carcinoma metastasis.
Hu YL; Feng Y; Chen YY; Liu JZ; Su Y; Li P; Huang H; Mao QS; Xue WJ
J Cell Mol Med; 2020 Jul; 24(13):7637-7651. PubMed ID: 32436333
[TBL] [Abstract] [Full Text] [Related]
15. Differences in Stage of cancer at Diagnosis, treatment, and Survival by Race and Ethnicity Among Leading cancer Types.
Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
[TBL] [Abstract] [Full Text] [Related]
16. Modified Child-Pugh grade
Huang F; Gao J
World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
[TBL] [Abstract] [Full Text] [Related]
17. [Effect of preoperative serum alanine aminotransferase and asparagine aminotransferase ratio on prognosis of patients with gastric cancer].
Han BL; Wang YM; Xue YW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):65-70. PubMed ID: 31958933
[No Abstract] [Full Text] [Related]
18. In-vitro Pre-treatment of cancer Cells with TGF-β1: A Novel Approach of Tail Vein Lung cancer Metastasis Mouse Model for Anti-Metastatic Studies.
Khan GJ; Sun L; Abbas M; Naveed M; Jamshaid T; Baig MMFA; Yuan S
Curr Mol Pharmacol; 2019; 12(4):249-260. PubMed ID: 30848226
[TBL] [Abstract] [Full Text] [Related]
19. Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours.
Martin V; Chiriaco C; Modica C; Acquadro A; Cortese M; Galimi F; Perera T; Gammaitoni L; Aglietta M; Comoglio PM; Vigna E; Sangiolo D
Br J Cancer; 2019 Mar; 120(5):527-536. PubMed ID: 30723303
[TBL] [Abstract] [Full Text] [Related]
20. Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis.
Masetti C; Lionetti R; Lupo M; Siciliano M; Giannelli V; Ponziani FR; Teti E; Dell'Unto C; Francioso S; Brega A; Montalbano M; Visco-Comandini U; Taibi C; Galati G; Vespasiani Gentilucci U; Picardi A; Andreoni M; Pompili M; Pellicelli AM; D'Offizi G; Gasbarrini A; De Santis A; Angelico M
J Viral Hepat; 2018 Dec; 25(12):1493-1500. PubMed ID: 30112854
[TBL] [Abstract] [Full Text] [Related]
[Next]
